🏥 Marengo Asia Hospitals • Gurugram & Faridabad, Delhi NCR

Bone Marrow Transplant in Gurgaon & Faridabad

Q: What Financial Assistance & Special Treatment Programs Are Available For BMT?

Treatment costs vary based on transplant type, conditioning regimen, and donor source. To ensure treatment is accessible, we provide dedicated Patient Funding Support Programs, institutional crowdfunding tie-ups, Compassionate Drug Access Programs for life-saving therapeutics, and eligible enrollment into active Clinical Trials.

Pioneering world-class Autologous, Allogeneic, and Haploidentical Stem Cell Transplants with advanced HEPA-filtered laminar air-flow BMT suites and multi-disciplinary transplant hematology expertise.

Schedule Specialist Consultation ➔ Call BMT Helpline 📞

1400+

Successful Transplants

90%+

Clinical Remission Rate

100%

HEPA Filtered Units

20+

Nations Treated

Specialized HSCT Modalities

Advanced Stem Cell Transplant Modalities

Every patient's cellular biology requires a tailored transplant protocol backed by high-resolution HLA matching.

Autologous Stem Cell Transplant

Uses the patient's own healthy hematopoietic stem cells collected prior to high-dose conditioning chemotherapy. Ideal for Multiple Myeloma, Relapsed Lymphomas, and select autoimmune conditions.

Low GVHD Risk • Shorter Hospital Stay

Allogeneic Stem Cell Transplant

Transplants stem cells from a fully matched related sibling donor or an unrelated registry donor (MUD). Provides a powerful Graft-versus-Leukemia (GVL) curative immune effect for acute leukemias.

Curative Approach • Full HLA Match

Haploidentical (Half-Matched) BMT

Utilizes half-matched family donors (parents, siblings, or children) through post-transplant cyclophosphamide (PTCy) regimens, eliminating the delay of finding a registry match for urgent leukemia cases.

Immediate Donor Availability • Delhi NCR Specialty

Comprehensive Clinical Scope

Hematological Conditions Treated Across NCR

Curative and consolidative transplant interventions across benign, malignant, pediatric, and genetic disorders.

Hematological Malignancies (Blood Cancers)

Acute Myeloid Leukemia (AML): High-risk and relapsed consolidation via Allogeneic BMT.
Acute Lymphoblastic Leukemia (ALL): Pediatric & adult targeted transplant regimens.
Multiple Myeloma & Plasma Cell Disorders: High-dose conditioning autologous rescue.
Hodgkin & Non-Hodgkin Lymphoma (NHL): Diffuse Large B-cell, Follicular, Mantle Cell.
Myelodysplastic Syndromes (MDS): Curative allogeneic stem cell grafting.
Chronic Myeloid Leukemia (CML): For accelerated, blast phase, or TKI-resistant cases.
Chronic Lymphocytic Leukemia (CLL): High-risk or relapsed disease pathways.
Myelofibrosis & MPNs: Primary myelofibrosis curative stem cell reconstitution.

Bone Marrow Failures & Hemoglobinopathies

Thalassemia Major: Curative matched sibling & haploidentical transplants.
Severe & Very Severe Aplastic Anemia (SAA/VSAA): Rapid-access first-line BMT.
Sickle Cell Disease (SCD): Curative stem cell transplant for recurrent vaso-occlusive crises.
Fanconi Anemia (FA): Low-intensity, specialized sensitivity conditioning protocols.
Pure Red Cell Aplasia (PRCA): Refractory bone marrow regeneration therapy.
Paroxysmal Nocturnal Hemoglobinuria (PNH): Curative allogeneic transplant options.
Diamond-Blackfan Anemia (DBA): Pediatric transfusion-independent stem cell cure.
Dyskeratosis Congenita: Tailored reduced-toxicity marrow failure protocols.

Immunodeficiency & Histiocytic Disorders

Severe Combined Immunodeficiency (SCID): Emergency life-saving pediatric transplants.
Hemophagocytic Lymphohistiocytosis (HLH): Familial and secondary refractory HLH protocols.
Wiskott-Aldrich Syndrome (WAS): Full immunological restoration with matched/haplo donor.
Chronic Granulomatous Disease (CGD): Permanent correction of neutrophil dysfunction.
Hyper IgM Syndrome & IPEX: Early intervention allogeneic cellular cures.
Leukocyte Adhesion Deficiency (LAD): Curative allogeneic stem cell graft.

Metabolic Inborn Errors & Solid Tumors

High-Risk Neuroblastoma: High-dose tandem autologous transplant protocols.
Relapsed Germ Cell Tumors & Ewing Sarcoma: Autologous stem cell rescue.
Adrenoleukodystrophy (X-ALD): Arresting cerebral demyelination via early allogeneic BMT.
Mucopolysaccharidosis (Hurler Syndrome / MPS I): Enzyme-restoring stem cell replacement.
Osteopetrosis (Infantile Malignant): Rescuing bone marrow space and cranial nerves.
Severe Autoimmune Diseases: Refractory Multiple Sclerosis (MS) & Scleroderma protocols.

Clinical Pathway

The BMT Treatment Journey At Marengo Asia Hospitals

A strictly supervised 4-phase journey designed to maximize immune reconstitution and patient safety.

Pre-Transplant Workup

Comprehensive organ function evaluations, high-resolution HLA typing, and donor verification.

Conditioning Therapy

Targeted chemotherapy or immunotherapy inside isolated positive pressure rooms to prepare the marrow.

Stem Cell Infusion

Painless intravenous stem cell transfusion (Day 0) performed under 24x7 hematologist monitoring.

Engraftment & Recovery

Daily absolute neutrophil tracking, antimicrobial prophylaxis, and tailored outpatient rehabilitation.

Common Queries

Frequently Asked Questions on BMT in Delhi NCR

What is the success rate of Bone Marrow Transplant in Gurgaon at BMT Next?

BMT Next at Marengo Asia Hospitals maintains world-standard clinical remission rates exceeding 85-90% for benign disorders like Thalassemia and matched sibling donor transplants, supported by dedicated HEPA-filtered positive pressure BMT ICUs and round-the-clock intensive care.

What Financial Assistance & Special Treatment Programs Are Available For BMT?

Transplant planning is customized based on individual diagnosis, donor source, and conditioning protocols. To ensure every eligible patient receives timely care without treatment interruption, Marengo Asia Hospitals provides:

• Patient Funding Support Program: Dedicated coordination for financial assistance, institutional medical grants, and trusted crowdfunding partnerships.
• Compassionate Drug Access Program: Facilitating early access to life-saving, specialized oncological drugs and advanced biologics.
• Active Clinical Trials: Opportunities for eligible patients to receive next-generation cellular protocols and novel investigational therapies under strict clinical supervision.

Who is an eligible stem cell donor for an Allogeneic Transplant?

A 100% matched sibling is the primary choice. In the absence of a sibling match, half-matched family donors (parents, children, siblings) are utilized for Haploidentical BMT, or international registries (DATRI, DKMS) are screened for matched unrelated donors (MUD).

Need an Expert Opinion on Bone Marrow Transplant?

Connect directly with our Lead Hematologists and Transplant Specialists at Marengo Asia Hospitals, Gurugram & Faridabad for comprehensive case evaluation.

Book Consultation ➔

BMT Next delivers advanced bone marrow transplant and hematology care through expert clinicians, globally aligned protocols, and a patient-first approach focused on safety and outcomes.